A project named Macustar has been launched with the aim of reducing the burden of AMD across Europe. Led by the University of Bonn, and involving UK input from UCL and Moorfields among others, the research will involve 700 AMD patients from 20 clinical si

In an exciting development, the U.S Food and Drug Administration (FDA) has given conditional approval to the makers of the world’s first commercial artificial retina to conduct a small-scale clinical trial of a brain implant designed to restore vision.

As the dust settles on last week’s Frankfurt Book Fair for another year, this one will be notable for the return of the seven-figure advance before the Fair had even got underway - proving that rumours of the demise of the printed word are very much exagg

In a time when a worldwide epidemic of myopia has been predicted, research into both its causes and prevention is of particular relevance. It used to be held that time spent staring close-up at screens in poor light was primarily to blame, but modern res

The basic physiology of vision has been understood for the best part of a century, but only in the last twenty years have scientists started to explore a second non-visual pathway by which the different colours we see affects our mind and body.

Scientists have discovered a dramatic link between weight loss following bariatric surgery and improved retina health, suggesting that blindness due to retinal damage may be reversible.

Harry Potter beware! Hard though it may seem to believe, Austrian boffins believe they have developed a technique for projecting light waves right through solid material.

Early warning for Glaucoma shows promise Researchers at University College London have developed a new test which they say could make it possible to detect and prevent Glaucoma up to a decade before any symptoms appear.

There are more than 10,000 accidents related to traffic every year in Singapore – a great many involving smartphone users. Advanced LED strips have been placed on the path near the edge of two very busy crossings picked to be part of a trial in an attemp

Phase 1 clinical trials have shown that a new therapy which uses viruses to introduce a gene into the eye is potentially safe for humans, and that it may be effective in preserving the vision of people with wet age-related macular degeneration.